Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers

被引:4
作者
Evans, D. Gareth [1 ]
Sithambaram, Siva [2 ]
van Veen, Elke Maria [3 ]
Burghel, George J. [4 ]
Schlecht, Helene [5 ]
Harkness, Elaine F. [3 ]
Byers, Helen [6 ]
Ellingford, Jamie M. [7 ]
Gandhi, Ashu [8 ]
Howell, Sacha J. [2 ,9 ]
Howell, Anthony [10 ]
Forde, Claire [11 ]
Lalloo, Fiona [12 ]
Newman, William G. [13 ]
Smith, Miriam Jane [14 ]
Woodward, Emma Roisin [15 ]
机构
[1] Univ Manchester, Div Evolut & Genom Sci, Sch Hlth Sci, Manchester M13 9WL, Lancs, England
[2] Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England
[3] Univ Manchester, Div Evolut & Genom Sci, Manchester, Lancs, England
[4] MFT, Genom Diagnost Lab, Manchester, Lancs, England
[5] Cent Manchester Univ Hosp NHS Fdn Trust, North West Genom Lab Hub, Manchester, Lancs, England
[6] Univ Manchester, Genom Med, Sch Hlth Sci Manchester, Manchester, Lancs, England
[7] Univ Manchester, Inst Human Dev, Sch Hlth Sci Manchester, Manchester, Lancs, England
[8] Wythenshawe Hosp Manchester Univ Fdn Trust, Prevent Breast Canc Ctr, Manchester, Lancs, England
[9] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England
[10] Manchester Fdn Trust, Prevent Breast Canc Ctr, Manchester, Lancs, England
[11] Cent Manchester Univ Hosp NHS Fdn Trust, Clin Genet Serv, Manchester, Lancs, England
[12] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Clin Genet Serv, Manchester, Lancs, England
[13] Univ Manchester, Genet, Sch Hlth Sci, Manchester, Lancs, England
[14] Univ Manchester, Genet Med, Sch Hlth Sci, Manchester, Lancs, England
[15] MFT, Manchester Ctr Genom Med, Manchester, Lancs, England
关键词
Genetics; Medical; BRCA2; MUTATIONS; WOMEN; PREVALENCE; PATHOLOGY;
D O I
10.1136/jmg-2022-108790
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
PurposeTo investigate frequency of germline pathogenic variants (PVs) in women with ductal carcinoma in situ (DCIS) and grade 1 invasive breast cancer (G1BC). MethodsWe undertook BRCA1/2 analysis in 311 women with DCIS and 392 with G1BC and extended panel testing (non-BRCA1/2) in 176/311 with DCIS and 156/392 with G1BC. We investigated PV detection by age at diagnosis, Manchester Score (MS), DCIS grade and receptor status. Results30/311 (9.6%) with DCIS and 16/392 with G1BC (4.1%) had a BRCA1/2 PV (p=0.003), and 24/176-(13.6%) and 7/156-(4.5%), respectively, a non-BRCA1/2 PV (p=0.004). Increasing MS was associated with increased likelihood of BRCA1/2 PV in both DCIS and G1BC, although the 10% threshold was not predictive for G1GB. 13/32 (40.6%) DCIS and 0/17 with G1BC <40 years had a non-BRCA1/2 PV (p<0.001). 0/16 DCIS G1 had a PV. For G2 and G3 DCIS, PV rates were 10/98 (BRCA1/2) and 9/90 (non-BRCA1/2), and 8/47 (BRCA1/2) and 8/45 (non-BRCA1/2), respectively. 6/9 BRCA1 and 3/26 BRCA2-associated DCIS were oestrogen receptor negative-(p=0.003). G1BC population testing showed no increased PV rate (OR=1.16, 95% CI 0.28 to 4.80). ConclusionDCIS is more likely to be associated with both BRCA1/2 and non-BRCA1/2 PVs than G1BC. Extended panel testing ought to be offered in young-onset DCIS where PV detection rates are highest.
引用
收藏
页码:740 / 746
页数:7
相关论文
共 21 条
[1]   Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ [J].
Claus, EB ;
Petruzella, S ;
Matloff, E ;
Carter, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (08) :964-969
[2]   Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women [J].
Dorling, Leila ;
Carvalho, Sara ;
Allen, Jamie ;
Gonzalez-Neira, Anna ;
Luccarini, Craig ;
Wahlstrom, Cecilia ;
Pooley, Karen A. ;
Parsons, Michael T. ;
Fortuno, Cristina ;
Wang, Qin ;
Bolla, Manjeet K. ;
Dennis, Joe ;
Keeman, Renske ;
Alonso, M. Rosario ;
Alvarez, Nuria ;
Herraez, Belen ;
Fernandez, Victoria ;
Nunez-Torres, Rocio ;
Osorio, Ana ;
Valcich, Jeanette ;
Li, Minerva ;
Torngren, Therese ;
Harrington, Patricia A. ;
Baynes, Caroline ;
Conroy, Don M. ;
Decker, Brennan ;
Fachal, Laura ;
Mavaddat, Nasim ;
Ahearn, Thomas ;
Aittomaki, Kristiina ;
Antonenkova, Natalia N. ;
Arnold, Norbert ;
Arveux, Patrick ;
Ausems, Margreet G. E. M. ;
Auvinen, Paivi ;
Becher, Heiko ;
Beckmann, Matthias W. ;
Behrens, Sabine ;
Bermisheva, Marina ;
Bialkowska, Katarzyna ;
Blomqvist, Carl ;
Bogdanova, Natalia V. ;
Bogdanova-Markov, Nadja ;
Bojesen, Stig E. ;
Bonanni, Bernardo ;
Borresen-Dale, Anne-Lise ;
Brauch, Hiltrud ;
Bremer, Michael ;
Briceno, Ignacio ;
Bruning, Thomas .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :428-439
[3]   Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing [J].
Evans, D. G. R. ;
Lalloo, F. ;
Cramer, A. ;
Jones, E. A. ;
Knox, F. ;
Amir, E. ;
Howell, A. .
JOURNAL OF MEDICAL GENETICS, 2009, 46 (12) :811-817
[4]   Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability [J].
Evans, D. Gareth ;
van Veen, Elke M. ;
Woodward, Emma R. ;
Harkness, Elaine F. ;
Ellingford, Jamie M. ;
Bowers, Naomi L. ;
Wallace, Andrew J. ;
Howell, Sacha J. ;
Howell, Anthony ;
Lalloo, Fiona ;
Newman, William G. ;
Smith, Miriam J. .
CANCERS, 2021, 13 (16)
[5]   High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer [J].
Evans, D. Gareth ;
van Veen, Elke Maria ;
Byers, Helen J. ;
Evans, Sarah J. ;
Burghel, George J. ;
Woodward, Emma Roisin ;
Harkness, Elaine F. ;
Eccles, Diana M. ;
Greville-Haygate, Stephanie L. ;
Ellingford, Jamie M. ;
Bowers, Naomi L. ;
Pereira, Marta ;
Wallace, Andrew J. ;
Howell, Sasha J. ;
Howell, Anthony ;
Lalloo, Fiona ;
Newman, William G. ;
Smith, Miriam Jane .
JOURNAL OF MEDICAL GENETICS, 2022, 59 (02) :115-121
[6]   Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel [J].
Evans, D. Gareth R. ;
van Veen, Elke M. ;
Harkness, Elaine F. ;
Brentnall, Adam R. ;
Astley, Susan M. ;
Byers, Helen ;
Woodward, Emma R. ;
Sampson, Sarah ;
Southworth, Jake ;
Howell, Sacha J. ;
Maxwell, Anthony J. ;
Newman, William G. ;
Cuzick, Jack ;
Howell, Anthony .
GENETICS IN MEDICINE, 2022, 24 (07) :1485-1494
[7]   Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal [J].
Ghadirian, P. ;
Robidoux, A. ;
Nassif, E. ;
Martin, G. ;
Potvin, C. ;
Patocskai, E. ;
Younan, R. ;
Larouche, N. ;
Venne, A. ;
Zhang, S. ;
Royer, R. ;
Narod, S. A. .
CLINICAL GENETICS, 2014, 85 (01) :31-35
[8]   Prevalence of BRCA1 and BRCA2 Mutations in Women with Breast Carcinoma In Situ and Referred for Genetic Testing [J].
Hall, Michael J. ;
Reid, Julia E. ;
Wenstrup, Richard J. .
CANCER PREVENTION RESEARCH, 2010, 3 (12) :1579-1585
[9]   A Population-Based Study of Genes Previously Implicated in Breast Cancer [J].
Hu, Chunling ;
Hart, Steven N. ;
Gnanaolivu, Rohan ;
Huang, Hongyan ;
Lee, Kun Y. ;
Na, Jie ;
Gao, Chi ;
Lilyquist, Jenna ;
Yadav, Siddhartha ;
Boddicker, Nicholas J. ;
Samara, Raed ;
Klebba, Josh ;
Ambrosone, Christine B. ;
Anton-Culver, Hoda ;
Auer, Paul ;
Bandera, Elisa V. ;
Bernstein, Leslie ;
Bertrand, Kimberly A. ;
Burnside, Elizabeth S. ;
Carter, Brian D. ;
Eliassen, Heather ;
Gapstur, Susan M. ;
Gaudet, Mia ;
Haiman, Christopher ;
Hodge, James M. ;
Hunter, David J. ;
Jacobs, Eric J. ;
John, Esther M. ;
Kooperberg, Charles ;
Kurian, Allison W. ;
Le Marchand, Loic ;
Lindstroem, Sara ;
Lindstrom, Tricia ;
Ma, Huiyan ;
Neuhausen, Susan ;
Newcomb, Polly A. ;
O'Brien, Katie M. ;
Olson, Janet E. ;
Ong, Irene M. ;
Pal, Tuya ;
Palmer, Julie R. ;
Patel, Alpa V. ;
Reid, Sonya ;
Rosenberg, Lynn ;
Sandler, Dale P. ;
Scott, Christopher ;
Tamimi, Rulla ;
Taylor, Jack A. ;
Trentham-Dietz, Amy ;
Vachon, Celine M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :440-451
[10]   Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers [J].
Krammer, Julia ;
Pinker-Domenig, Katja ;
Robson, Mark E. ;
Gonen, Mithat ;
Bernard-Davila, Blanca ;
Morris, Elizabeth A. ;
Mangino, Debra A. ;
Jochelson, Maxine S. .
BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) :565-571